drugset / Trial / NCT00840073

Trandolapril 4 mg Tablet Under Non-Fasting Conditions

NCT00840073

Phase 1 Completed 50 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to evaluate the comparative bioavailability between trandolapril 4 mg tablets (test) and Mavik® 4 mg Tablets (reference) after a single-dose in healthy subjects under fed conditions.

Timeline

Start
2004-10
Primary completion
2004-11
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject trandolapril Small molecule 4 mg

Indications

No indication recorded.